Horizon Discovery Limited

Horizon Discovery Limited

Personalized medicine company

Horizon developed a range of research tools and other products and services based on gene editing technologies. These were sold primarily into the pharmaceutical industry for the development of medicines, in particular for cancer.

Horizon went public on AIM in 2016.